US09073M1045
© PR Newswire
09.12.2025
TECH
LISTED
NASDAQ
Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis
News Preview
Combines chemiluminescence detection with dual-channel fluorescence in the near-infrared and infrared (NIR and IR) ranges for expanded multiplexingEnables up to 24 targets per sample and supports complex assay configurationsStrengthens Bio-Techne's leadership in proteomic analytical instruments and supports 21 CFR Part 11 complianceMINNEAPOLIS, De...
Themefolio
Profiler
Peergroup
© PR Newswire
25.11.2025
TECH
LISTED
NASDAQ
Bio-Techne to Present at Upcoming Investor Conferences
News Preview
MINNEAPOLIS, Nov. 25, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:8th Annual Evercore Healthcare Conference 2025December 2, 20258:20 AM ESTCiti's 2025 Global Healthcare ConferenceDecember 3, 20253:15 PM EST53rd Annual Nasdaq Investor ConferenceDecember 9, 202...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
TECH
LISTED
NASDAQ
Bio-Techne to Present at Upcoming Investor Conferences
News Preview
MINNEAPOLIS, Nov. 6, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:
UBS Global Healthcare Conference 2025 November 10, 2025 10:15 AM EST
Stifel 2025 Healthcare Conference November 11, 2025 9:20...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
05.11.2025
TECH
LISTED
NASDAQ
BIO-TECHNE DECLARES DIVIDEND
News Preview
MINNEAPOLIS, Nov. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended September 30, 2025. The quarterly dividend will be payable November 28, 2025, to all common shareholders of record on Novembe...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
04.11.2025
TECH
LISTED
NASDAQ
AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients
News Preview
Clinical trial data demonstrates how Bio-Techne's spatial biology technology and Nucleai's AI-powered multimodal platforms can identify predictive biomarkers in immunotherapy and targeted therapy-treated melanoma patients.
Bio-Techne's COMET™ platform and Nucleai's multimodal spatial operating...
Themefolio
Profiler
Peergroup
© PR Newswire
28.10.2025
TECH
LISTED
NASDAQ
Bio-Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
News Preview
Visualizes functional protein-protein interactions directly within fixed tissue at subcellular resolution
Enables simultaneous detection of protein proximity, RNA, and proteins on the same tissue section
Automates spatial multiomic workflows with the BOND RX platform from Leica...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
TECH
LISTED
NASDAQ
Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
News Preview
Saguaro Biosciences, a pioneer in non-toxic live cell reagents for enhanced drug insights, announces a new distribution agreement with Bio-Techne Corporation (NASDAQ:TECH), a global provider of life science tools, reagents and diagnostic products. The partnership will leverage Bio-Techne’s extensive international sales and marketing channels to pr...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
TECH
LISTED
NASDAQ
Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results
News Preview
MINNEAPOLIS, Oct. 15, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, November 5, 2025, at 8:00 a.m. CST to review its first quarter fiscal 2026 financial results.
Access to the discussion may be obtai...
Themefolio
Profiler
Peergroup
© PR Newswire
26.09.2025
TECH
LISTED
NASDAQ
Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications
News Preview
RNAscope™ technology and the Lunaphore COMET™ enable simultaneous RNA and protein detection on the same tissue sectionTechnologies support spatial multiomic analysis and deeper insights for pathology workflowsResearch highlights potential role in clinical utility workflows for lymphoid malignancies and B-cell clonalityMINNEAPOLIS, Sept. 26, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2025
TECH
LISTED
NASDAQ
Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report
News Preview
Company advances transition to renewable electricity and sets a pathway to science-based emissions reductions
MINNEAPOLIS, Sept. 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today released its 2025 Corporate Sustainability Report, underscoring the compa...
Themefolio
Profiler
Peergroup
© PR Newswire
09.09.2025
TECH
LISTED
NASDAQ
ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California
News Preview
ST. PAUL, Minn., Sept. 9, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that eight (8) G-Rex Grants, totaling nearly $2 million in support, have been awarded to awardees of the California Institute for Regenerative Medicine (CIRM) Manufacturin...
Themefolio
Profiler
Peergroup
© PR Newswire
14.08.2025
TECH
LISTED
NASDAQ
ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory
News Preview
ST. PAUL, Minn., Aug. 14, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that the Translational Sciences Laboratory at Gates Institute, a leading contract development and manufacturing organization (CDMO) based at the University of Colorado Anschutz Medical C...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
17.07.2025
TECH
LISTED
NASDAQ
Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results
News Preview
MINNEAPOLIS, July 17, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, August 6, 2025, at 8:00 a.m. CDT to review its fourth quarter and fiscal 2025 financial results.
Access to the discussion may be obtained as follows:
Time:
8:00 a.m. CDT
Date:
Augus...
Themefolio
Profiler
Peergroup
© BusinessWire
15.07.2025
TECH
LISTED
NASDAQ
Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
News Preview
Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, is pleased to announce a strategic distribution partnership with Bio-Techne Corporation (NASDAQ: TECH), a global leading provider of innovative reagents, instruments, and solutions for life-science research and clinical diagnostics. The partnership sig...
Themefolio
Profiler
Peergroup
© PR Newswire
15.07.2025
TECH
LISTED
NASDAQ
Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
News Preview
MINNEAPOLIS, July 15, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership to distribute Spear Bio's next-generation ultrasensitive immunoassays, enabling the detection of low-abundance biomarkers in neurology. Under the agreement, Bio-Techne will distribute Spear Bio's ultrasensitive immunoassays for c...
Themefolio
Profiler
Peergroup
© PR Newswire
14.07.2025
TECH
LISTED
NASDAQ
Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy
News Preview
MINNEAPOLIS, July 14, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first autologous cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), developed by...
Themefolio
Profiler
Peergroup
© PR Newswire
24.06.2025
TECH
LISTED
NASDAQ
Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
News Preview
MINNEAPOLIS, June 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a distribution agreement with the U.S. Pharmacopeia (USP) that enables the Company to sell USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV) reference standards with its analytical solutions, including the Maurice system, to s...
Themefolio
Profiler
Peergroup
© PR Newswire
10.06.2025
TECH
LISTED
NASDAQ
ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics
News Preview
ST. PAUL, Minn., June 10, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Immuneel Therapeutics has been awarded a $150,000 G-Rex® Grant to support process development aimed at enhancing the scalability and cost-effectiveness of CAR-T cell manufacturing i...
Themefolio
Profiler
Peergroup
© PR Newswire
29.05.2025
TECH
LISTED
NASDAQ
Bio-Techne to Present at Investor Conferences
News Preview
MINNEAPOLIS, May 29, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:
William Blair 45th Annual Growth Stock ConferenceJune 3, 20252:40 PM CDT
Jefferies Global Healthcare ConferenceJune 4, 20253:45 PM EDT
Goldman Sachs 46th Annual Global Healthcare ConferenceJun...
Themefolio
Profiler
Peergroup
© PR Newswire
14.05.2025
TECH
LISTED
NASDAQ
ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA)
News Preview
ST. PAUL, Minn., May 14, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady announced today three G-Rex Grants that have been awarded to faculty members at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA). The funding to...
Themefolio
Profiler
Peergroup
© PR Newswire
12.05.2025
TECH
LISTED
NASDAQ
Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
News Preview
MINNEAPOLIS, May 12, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its latest spatial biology and cell and gene therapy workflow solutions at the American Society of Gene & Cell Therapy (ASGCT) 2025 meeting taking place in New Orleans between May 13th – 17th at the New Orleans Ernest N. Morial Con...
Themefolio
Profiler
Peergroup
© PR Newswire
08.05.2025
TECH
LISTED
NASDAQ
Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
News Preview
Kytopen and Bio-Techne announce partnership on an integrated cellular engineering workflow to expedite cell therapy manufacturing.The TcBuster™ system offers a fast and scalable method to integrate large, multigene cargos with high editing efficiency in a single vector, while Flowfect® continuous flow technology enables the gentle, high-efficienc...
Themefolio
Profiler
Peergroup
© PR Newswire
08.05.2025
TECH
LISTED
NASDAQ
Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
News Preview
MINNEAPOLIS, May 8, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 10:40 a.m. PDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Te...
Themefolio
Profiler
Peergroup
© PR Newswire
07.05.2025
TECH
LISTED
NASDAQ
BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
News Preview
MINNEAPOLIS, May 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended March 31, 2025. The quarterly dividend will be payable May 30, 2025, to all common shareholders of record on May 19, 2025. Future cash dividends will be conside...
Themefolio
Profiler
Peergroup
© PR Newswire
07.05.2025
TECH
LISTED
NASDAQ
BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
News Preview
MINNEAPOLIS, May 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ending March 31, 2025.
Third Quarter FY2025 Highlights
Third quarter organic revenue increased by 6% (4% reported) to $316.2 million.GAAP earnings per share (EPS) was $0.14 versus $0.31 one year ago. Delivered...
Themefolio
Profiler
Peergroup
© PR Newswire
06.05.2025
TECH
LISTED
NASDAQ
ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc.
News Preview
ST. PAUL, Minn., May 6, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf, Bio-Techne Corporation and CellReady, today announced that A2 Biotherapeutics, Inc. ("A2") has been awarded a $300,000 G-Rex® Grant. A2's G-Rex® Grant will enable expeditious process development and qualification of a G-Rex-based production system and wil...
Themefolio
Profiler
Peergroup
© PR Newswire
29.04.2025
TECH
LISTED
NASDAQ
ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy
News Preview
ST. PAUL, Minn., April 29, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that March Biosciences has been awarded a $200,000 G-Rex® Grant. March Biosciences' G-Rex® Grant will be used to advance the manufacturing of their lead asset, MB-105, a novel investiga...
Themefolio
Profiler
Peergroup
© PR Newswire
24.04.2025
TECH
LISTED
NASDAQ
Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
News Preview
New assay enables high-resolution spatial visualization of protein interactions, unlocking functional insights within complex tissues
MINNEAPOLIS, April 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of cutting-edge life science tools, today announced an Early Access Program for its latest advancement in spatial...
Themefolio
Profiler
Peergroup
© PR Newswire
23.04.2025
TECH
LISTED
NASDAQ
Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
News Preview
MINNEAPOLIS, April 23, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its latest advancements in cancer research tools at the 2025 American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30 at McCormick Place Convention Center in Chicago, IL. Bio-Techne's booths will featu...
Themefolio
Profiler
Peergroup
© PR Newswire
15.04.2025
TECH
LISTED
NASDAQ
Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results
News Preview
MINNEAPOLIS, April 15, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 7, 2025, at 8:00 a.m. CDT to review its third quarter fiscal 2025 financial results.
Access to the discussion may be obtained as follows:
Time:
8:00 a.m. CDT
Date: ...
Themefolio
Profiler
Peergroup
© PR Newswire
02.04.2025
TECH
LISTED
NASDAQ
Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
News Preview
MINNEAPOLIS, April 2, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD), and Leica Biosystems, a global leader in anatomic pathology solutions. The expanded spatial multiomic collaboration now includes automatio...
Themefolio
Profiler
Peergroup
© PR Newswire
26.03.2025
TECH
LISTED
NASDAQ
Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany
News Preview
MINNEAPOLIS, March 26, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will open a new Customer Experience Centre in Düsseldorf, Germany to serve customers across the Europe, Middle East and Africa (EMEA) region and support the company's long-term regional growth strategy.
The new Customer Experience Centre is schedu...
Themefolio
Profiler
Peergroup
© PR Newswire
24.03.2025
TECH
LISTED
NASDAQ
Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
News Preview
MINNEAPOLIS, March 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by leveraging RNAscope technology to address unmet needs in biomarker detection and improve pathology laboratory workflows. These advancements will be hig...
Themefolio
Profiler
Peergroup
© PR Newswire
03.03.2025
TECH
LISTED
NASDAQ
Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
News Preview
AmplideX® Nanopore Carrier Plus Kit uses nanopore sequencing to resolve high-prevalence genes.
MINNEAPOLIS and OXFORD, England, March 3, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Asuragen, a Bio-Techne brand, has teamed up with Oxford Nanopore Technologies to launch the AmplideX® Nanopore Carrier Plus Kit, a...
Themefolio
Profiler
Peergroup
© PR Newswire
20.02.2025
TECH
LISTED
NASDAQ
Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
News Preview
MINNEAPOLIS, Feb. 20, 2025 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of an expanded menu of human and mouse RNAscope™ in situ hybridization probes to advance spatial biology research and the development of next-generation therapeutics and diagnostics. Designed to deli...
Themefolio
Profiler
Peergroup
© PR Newswire
18.02.2025
TECH
LISTED
NASDAQ
Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
News Preview
MINNEAPOLIS, Feb. 18, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools, is pleased to announce the official release of GMP Transposase mRNA for the TcBuster™ non-viral genome engineering system, supporting the development and manufacture of immune cell- and stem cell-based th...
Themefolio
Profiler
Peergroup
© PR Newswire
05.02.2025
TECH
LISTED
NASDAQ
Bio-Techne Releases Second Quarter Fiscal 2025 Results
News Preview
MINNEAPOLIS, Feb. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ending December 31, 2024.
Second Quarter FY2025 Highlights
Second quarter organic revenue increased by 9% (9% reported) to $297.0 million.GAAP earnings per share (EPS) was $0.22 versus $0.17 one year ago. Del...
Themefolio
Profiler
Peergroup
© PR Newswire
05.02.2025
TECH
LISTED
NASDAQ
Bio-Techne Declares Dividend
News Preview
MINNEAPOLIS, Feb. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended December 31, 2024. The quarterly dividend will be payable February 28, 2025, to all common shareholders of record on February 17, 2025. Future cash dividends w...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2025
TECH
LISTED
NASDAQ
Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
News Preview
MINNEAPOLIS, Feb. 4, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Amy E. Herr, Ph.D. to serve as an independent director on the Company's Board of Directors beginning on February 1, 2025. Dr. Herr will serve on the Science & Technology Committee of the Board of Directors.
Dr. Herr is a Chancell...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2025
TECH
LISTED
NASDAQ
Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results
News Preview
MINNEAPOLIS, Jan. 21, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, February 5, 2025, at 8:00 a.m. CST to review its second quarter fiscal 2025 financial results.
Access to the discussion may be obtained as follows:
Time:
8:00 a.m. CST
Date:
Februar...
Themefolio
Profiler
Peergroup
© PR Newswire
21.01.2025
TECH
LISTED
NASDAQ
ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio
News Preview
ST. PAUL, Minn., Jan. 21, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that BrainChild Bio has been awarded a $300,000 G-Rex® Grant. The G-Rex® Grant will support expeditious process development and commercial readiness of BCB-276, BrainChild Bio's lead aut...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2025
TECH
LISTED
NASDAQ
ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics
News Preview
ST. PAUL, Minn., Jan. 8, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing and Bio-Techne Corporation, today announced that Seattle Children's Therapeutics, a division of the Seattle Children's Research Institute has been awarded a $125,000 G-Rex Grant. The G-Rex Grant will integrate state-of-the-art advancements i...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2025
TECH
LISTED
NASDAQ
BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
News Preview
MINNEAPOLIS, Jan. 8, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its new ProPak™ GMP cytokines, alongside its portfolio of innovative products and solutions supporting cell and gene therapy development and manufacturing at Phacilitate's Advanced Therapies Week, taking place January 20-23 at the Kay...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2025
TECH
LISTED
NASDAQ
BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
News Preview
MINNEAPOLIS, Jan. 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it prevailed on another claim that Miltenyi Biotec B.V. & Co. KG commercialized antibodies developed based on information obtained by reverse engineering Bio-Techne's proprietary R&D Systems branded NKG2C/CD159c antibodies. This follows a...
Themefolio
Profiler
Peergroup
© PR Newswire
20.12.2024
TECH
LISTED
NASDAQ
BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
News Preview
MINNEAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 10:30 a.m. PST. A live webcast of the presentation can be accessed via the IR Calendar page o...
Themefolio
Profiler
Peergroup
© PR Newswire
19.12.2024
TECH
LISTED
NASDAQ
BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
News Preview
MINNEAPOLIS, Dec. 19, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leader in automated platforms for biotherapeutic characterization, today announced a co-marketing and co-promotion agreement with Waters Corporation aimed at expanding the reach of advanced biotherapeutic characterization and development processes. The companies p...
Themefolio
Profiler
Peergroup
© PR Newswire
18.12.2024
TECH
LISTED
NASDAQ
ScaleReady awards a G-Rex® Grant to Moonlight Bio
News Preview
ST. PAUL, Minn., Dec. 18, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that Moonlight Bio has been awarded a G-Rex® Grant. Moonlight Bio's G-Rex® Grant will expedite process development and IND-enabling studies of their lead CAR T cell therap...
Themefolio
Profiler
Peergroup
© PR Newswire
12.12.2024
TECH
LISTED
NASDAQ
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
News Preview
MINNEAPOLIS, Dec. 12, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities today announced a partnership with MedSanTek. Under the agreement, MedSanTek becomes the distributor of Bio-Techne's R&D Systems...
Themefolio
Profiler
Peergroup
© PR Newswire
10.12.2024
TECH
LISTED
NASDAQ
BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
News Preview
Company will showcase new assay at the upcoming San Antonio Breast Cancer Symposium
MINNEAPOLIS, Dec. 10, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Asuragen, a Bio-Techne brand, launched a highly sensitive ESR1 mutation monitoring assay. ESR1 gene mutations are known to be linked to hormone receptor-positive...
Themefolio
Profiler
Peergroup
© PR Newswire
27.11.2024
TECH
LISTED
NASDAQ
BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
News Preview
MINNEAPOLIS, Nov. 27, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the Citi 2024 Global Healthcare Conference on Wednesday, December 4, 2024, at 3:15 p.m. EST. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-...
Themefolio
Profiler
Peergroup
© PR Newswire
25.11.2024
TECH
LISTED
NASDAQ
Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne
News Preview
WEST SACRAMENTO, Calif., Nov. 25, 2024 /PRNewswire/ -- Gemini Bioproducts, LLC ("GeminiBio"), a leading supplier of cell culture reagents and process liquids, and a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Florida-based healthcare private equity firm, today announced the acquisition of selected fetal bovine serum (...
Themefolio
Profiler
Peergroup
© PR Newswire
20.11.2024
TECH
LISTED
NASDAQ
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
News Preview
MINNEAPOLIS, Nov. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities today announced a partnership with Leader Life Sciences. Under the agreement, Leader Life Sciences becomes a distributor of Bio-Tech...
Themefolio
Profiler
Peergroup
© PR Newswire
18.11.2024
TECH
LISTED
NASDAQ
BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
News Preview
MINNEAPOLIS, Nov. 18, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership with ALZpath, Inc to accelerate breakthroughs in neurodegenerative disease research and treatment, including Alzheimer's disease. The collaboration leverages Bio-Techne's Ella™ fully automated, multiplexing immunoassay platform...
Themefolio
Profiler
Peergroup
© PR Newswire
14.11.2024
TECH
LISTED
NASDAQ
BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
News Preview
Customers will present data from their use of novel assays and kits; company will host educational workshops and discussions for attendees
MINNEAPOLIS, Nov. 14, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced its lineup of presentations and activities for the Association for Molecular Pathology (AMP) 2024 Annual Meeting...
Themefolio
Profiler
Peergroup
© PR Newswire
11.11.2024
TECH
LISTED
NASDAQ
UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
News Preview
R&D Systems Hematology Controls and Calibrators has completed the Class B Certification under the new European Union In Vitro Diagnostic Regulation
This press release updates the IVDR Classification to Class B from the prior Class C.
MINNEAPOLIS, Nov. 11, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) has recently achieved In Vit...
Themefolio
Profiler
Peergroup
© PR Newswire
11.11.2024
TECH
LISTED
NASDAQ
BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
News Preview
R&D Systems Hematology Controls and Calibrators has completed the Class C Certification under the new European Union In Vitro Diagnostic Regulation
MINNEAPOLIS, Nov. 11, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) has recently achieved In Vitro Diagnostic Regulation (IVDR) certification for its R&D Systems Hematology Contro...
Themefolio
Profiler
Peergroup
© PR Newswire
08.11.2024
TECH
LISTED
NASDAQ
BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
News Preview
MINNEAPOLIS, Nov. 8, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:
UBS Global Healthcare ConferenceNovember 12, 20249:30 AM PST
Stifel 2024 Healthcare ConferenceNovember 19, 20248:00 AM EST
Stephens NASH 2024 ConferenceNovember 20, 202411:00 AM CST
A live web...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2024
TECH
LISTED
NASDAQ
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy
News Preview
ST. PAUL, Minn., Nov. 7, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing and Bio-Techne Corporation and CellReady, has awarded G-Rex Grants totaling $475,000 to three leading investigators at the Baylor College of Medicine's (BCM) Center for Cell and Gene Therapy Institute (CAGT).
Dr. Ann Leen, a Professor in the...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2024
TECH
LISTED
NASDAQ
BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
News Preview
MINNEAPOLIS, Nov. 6, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its market-leading portfolio to advance cancer research from target discovery to personalized medicine and cell therapy development at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting, taking place November 6-10, 2024...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2024
TECH
LISTED
NASDAQ
LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
News Preview
MINNEAPOLIS, Nov. 5, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the release of clinically relevant spatial biology data. The data was generated using Bio-Techne's Lunaphore branded end-to-end spatial biology offering, including its complete range of instruments (COMET) and kits that offer high-value solutions for t...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
